TUESDAY MAY 4
Taxis are plentiful (when the weather is nice) and reasonably priced. Fares are a $2 initial charge, plus 30 cents per 1/5 mile traveled, plus 20 cents per minute of waiting time. There is a 50-cent surcharge after 8 p.m. Riders must also pay any bridge or tunnel tolls. (Copyright Jeff Greenberg/NYC & Company, Inc.)
7 a.m.-8:30 a.m.
Industry-Supported Breakfast Symposia
IS31. New Advances in the Treatment of Psychosis (Part 2) Supported by Bristol-Myers Squibb Company
A. Antipsychotic Therapies in Geriatric Patients: The Importance of Safety and Tolerability J. Michael Ryan, M.D.
B. Unique Challenges in the Pharmacotherapy of First-Episode Schizophrenia Joseph P. McEvoy, M.D.
Shea Stadium, in the New York borough of Queens, home of the New York Mets, is just a subway ride from midtown Manhattan. (Copyright Michael N. Paras/NYC & Company, Inc.)
IS32. Current Alzheimer’s Disease Treatments and Beyond: Advances Impacting Clinical Practice (Part 2) Supported by Forest Laboratories Inc.
A. Neuroimaging in Alzheimer’s Disease: Diagnosis, Treatment, and Prevention P. Murali Doraiswamy, M.D.
B. New Treatment Strategies for Alzheimer’s Disease: The Role of Early Diagnosis Trey Sunderland, M.D.
IS33. Recognizing the Many Faces of Bipolar Disorder (Part 2) Supported by Eli Lilly and Company
A. Optimizing Functional Outcome in Bipolar Disorder Deborah A. Yurgelun-Todd, Ph.D.
B. Neuroimaging Findings in Bipolar Disorder Stephan H. Heckers, M.D.
C. New Directions in Medication Development for Bipolar Disorder Bruce M. Cohen, M.D.
IS34. Evidence-Based Medicine: The Next Generation (Part 2) Supported by Wyeth Pharmaceuticals
A. Psychotherapy for Treatment of Depression: Recent Developments Thomas Lynch, M.D.
B. Pharmacological Treatment of Agitation in Dementia: Evidence-Based Recommendations Warren D. Taylor, M.D.
IS35. Transcending Efficacy: Effective Treatment of Psychosis Across Disorders (Part 2) Supported by AstraZeneca Pharmaceuticals
A. Avoiding Comorbidities in Treatment John W. Newcomer, M.D.
B. Transcending Efficacy in Psychosis: Where the Rubber Meets the Road Jeanne Jackson-Siegel, M.D.
7:30 a.m.-6 p.m.
Registration/Course Enrollment Open
8 a.m.-Noon
CME Courses 53-61
9 a.m.-10:30 a.m.
Clinical Case Conference 2. Christine E. Skotzko, M.D., Lynnette Krueger, M.S.N., Maria A. Rueda-Lara, M.D., on Assessing and Treating Psychiatric Symptoms in Individuals With Cardiovascular Disease (Open to APA members only.)
Discussion Groups
10. Robert I. Simon, M.D., on Assessing and Managing Suicide Risk: Clinically Based Guidelines for Risk Management (Meet the Authors)
11. Peter V. Rabins, M.D., on What Can Brain Diseases Teach Us About the Mind-Brain Interface?
12. Salman Akhtar, M.D., on Cross-Cultural Psychotherapy
13. Altha J. Stewart, M.D., on Public Psychiatry: Leading the Way in Transforming Service Delivery in the 21st Century
Lectures
L12. Adventures in Psychiatric Research: Neurobiology to Public Policy Jack D. Barchas, M.D., J. Christian Gillin, M.D. (Posthumously), APA’s Research in Psychiatry Award Lecture
L13. Why Does the Human Brain Become Addicted? Nora D. Volkow, M.D., Collaborative Session With the National Institute on Drug Abuse, Distinguished Psychiatrist Lecture Series
Master Educator Clinical Consultation 5.Francisco Fernandez, M.D., on Neuropsychiatric Complications of HIV-I Infection (Open to APA members only.)
Round-Table Discussion: Coercion and Treatment: Medical, Legal, and Ethical Issues Moderator: Carol Fisler, J.D.
Component Workshops
CW21. The Neurobiology of Self-Awareness: Learning From Autism and BPD About How We Know Ourselves APA Committee on Psychotherapy by Psychiatrists Chairperson: Bernard D. Beitman, M.D.
CW22. Blood on the Floor: Responding to Catastrophic Events and High Risks APA Committee on Standards and Survey Procedures Chairperson: Steven I. Altchuler, M.D.
CW23. The Ties That Bind: Considerations of Culture and Family in Mental Health Treatment APA/SAMHSA Minority Fellowship Selection and Program Corresponding Committee Chairperson: Timothy G. Benson, M.D.
CW24. Universal Health Care and Other Models APA Council on Healthcare Systems and Financing Chairperson: Barry F. Chaitin, M.D.
CW25. Revision of the APA Ethics Annotations: Fostering Dialogue APA Task Force to Update the Ethics Annotations Chairperson: Laura W. Roberts, M.D.
CW26. The Juvenile Justice System: Assessment, Services, and Data Use APA Corresponding Committee on Juvenile Justice Issues Co-Chairpersons: R. Gregg Dwyer, M.D. and Carl C. Bell, M.D.
Issue Workshops
IW33. Mental Health Needs of Our Soldiers and Their Families Chairperson: Howard J. Osofsky, M.D.
IW34. The Impact of Migration on Addictive Disorders: A Challenge for the Americas Collaborative Session With the National Institute on Drug Abuse Chairperson: Amelia Musacchio de Zan, M.D.
IW35. The Clinical Impact of Treating Civil and Criminally-Mandated Psychiatric Patients Co-Chairpersons: Merrill R. Rotter, M.D. and Ali Khadivi, Ph.D.
IW36. Using Cognitive Therapy for Psychosis in Psychiatric Practice Chairperson: David G. Kingdon, M.D.
IW37. The Theater of Emotions Chairperson: Ian E. Alger, M.D.
IW38. Initial Psychiatric Interview: A Psychodynamic Approach to 90801 American Academy of Psychoanalysis and Dynamic Psychiatry Chairperson: Gopalakrishna K. Upadhya, M.D.
IW39. How to Launch a Successful Private Practice(Part 1) Co-Chairpersons: William E. Callahan, Jr., M.D. and Keith W. Young, M.D.
IW40. My Name is Walter James Cross Chairperson: David L. Dawson, M.D.
IW41. Online Video Games: Psychopathological or Psychotherapeutic? Co-Chairpersons: Jeffrey N. Wilkins, M.D. and Jack Kuo, M.D.
IW42. Infertility: A Chronic Illness With Chronic Challenges Chairperson: Roxanne C. Dryden-Edwards, M.D.
IW43. Values-Based Treatment of Relational Disorders Co-Chairpersons: Glenn N. Siegel, M.D. and Mary Pittman, M.S.
IW44. Oral Boards Boot Camp Co-Chairpersons: Elyse D. Weiner, M.D. and Eric D. Peselow, M.D.
IW45. Steroid Abuse: Growing Problem for Adolescents and a Hidden Problem for Adults Collaborative Session With the National Institute on Drug Abuse Chairperson: Donald R. Vereen, Jr., M.D.
IW46. Engaging the Homeless in Treatment Strategies and Results Chairperson: John S. McIntyre, M.D.
IW47. New Technologies for the Assessment of ADHD Co-Chairpersons: Martin H. Teicher, M.D. and Gianni L. Faedda, M.D.
IW48. Emerging Pharmacotherapies for Treatment of Stimulant Dependence Collaborative Session With the National Institute on Drug Abuse Chairperson: Francis J. Vocci, Ph.D.
IW49. Update on Hepatitis C and Psychiatric Issues Co-Chairpersons: Andrew F. Angelino, M.D. and Glenn J. Treisman, M.D.
IW50. Fibromyalagia: Current Understanding and Future Directions Chairperson: Alan Z.A. Manevitz, M.D.
IW51. The Art of the Unconscious: Shakespeare, Poetry, Film, and Psychiatry Co-Chairpersons: Steven E. Pflanz, M.D. and Charles R. Joy, M.D.
IW52. The Impact of 9/11 on Psychiatric Residents and Training Programs Chairperson: Renato D. Alarcon, M.D.
IW53. Implementing the Institute of Medicine Report: Fostering Research Careers via Residencies Chairperson: Joel Yager, M.D.
IW54. A Shared-Care Model for Treating the Homeless Mentally Ill Chairperson: Samuel Packer, M.D.
IW55. Group Interventions With Adolescents in Outpatient, Inpatient, and School Settings Chairperson: Fady Hajal, M.D.
IW56. Addiction Research as a Career Choice in Psychiatry Collaborative Session With the National Institute on Drug Abuse Chairperson: Ivan D. Montoya, M.D.
IW57. It Doesn’t Happen to Us: Exploring Trauma and Resiliency in Minorities Co-Chairpersons: Napoleon B. Higgins, Jr., M.D. and Lacresha L. Hall, M.D.
IW58. Cutting-Edge Management of Tourette’s Syndrome and Its Comorbidities Co-Chairpersons: Cathy L. Budman, M.D. and John T. Walkup, M.D.
9 a.m.-11 a.m.
Research Advances in Medicine
The Epidemiology and Treatment of Psychiatric Comorbidities Collaborative Session With the National Institute on Drug Abuse Chairperson: Geetha Jayaram, M.D., Co-Chairperson: Joel J. Wallack, M.D.
9 a.m.-Noon
Continuous Clinical Case Conference 1. James L. Griffith, M.D., Lynne M. Gaby, M.D., Julia B. Frank, M.D., Robert W. Keisling, M.D., and Jeffrey S. Akman, M.D. on Helping Patients Counter Demoralization While Living With a Chronic or Recurrent Psychiatric Illness (Part 2) (Open to APA members only.)
Media Workshops
MW3. Cultural Assessment in Clinical Psychiatry: Two Training Videotapes Co-Chairpersons: Francis Lu M.D. and Harriett Koskoff
MW4. “When Boys Fly”: Club Drugs in the Gay Male Community Chairperson: Petros Levounis, M.D.
9 a.m.-12:30 p.m.
Review of Psychiatry (Section 1) Neuropsychiatric Assessment Chairperson: Stuart C. Yudofsky, M.D.; Co-Chairperson: Florence Kim, M.D.
1. Neuropsychiatric Physical Diagnosis in Context Fred Ovsiew, M.D.
2. Neurological and Neuropsychological Exam of the Psychiatric Patient Mark Lovell, Ph.D.
3. Electrophysiological Testing Nashaat N. Boutros, M.D.
4. Neuropsychiatric Lab Testing Florence Kim, M.D.
5. Selected Neuroimaging Topics in Psychiatric Disorders Thomas E. Nordahl, M.D.
9 a.m.-4 p.m.
CME Courses 62-68
10 a.m.-6 p.m.
Exhibits Open
APA Exhibit Open
Publishers’ Bookfair Open
11 a.m.-12:30 p.m.
Discussion Groups
14. Joel F. Paris, M.D., on Personality Disorders Over Time (Meet the Authors)
15. Barton J. Blinder, M.D., on Psychiatric Comorbidity in the Eating Disorders: Diagnosis, Treatment, and Research
16. Paul S. Appelbaum, M.D., on Ethics in Psychiatric Practice
17. Nancy C. Andreasen, M.D., on Publishing and Grant Writing (For Residents Only)
Lectures
L14. Dialogue From the Rims of the Grand Canyon: On Bridging the Post-Freudian Chasm Between Religion and Psychiatry Elizabeth S. Bowman, M.D., APA’s Oskar Pfister Award Lecture
L15. Anticraving Medication: A New Class of Psychoactive Medication? Charles P. O’Brien, M.D., Collaborative Session With the National Institute on Drug Abuse, Frontiers of Science Lecture Series
Master Educator Clinical Consultations
6. Mark E. Servis, M.D., on Personality Disorders (Open to APA members only.)
7. Ira D. Glick, M.D., on Combining and Integrating Medication and Psychotherapy for Schizophrenia and Other Axis 1 Disorders (Open to APA members only.)
Medical Update 2. Robert S. Brown, Jr., M.D., on Hepatitis B and C: What’s New?
Research Consultation 2. Matcheri S. Keshavan, M.D., on Brain Imaging Studies in Schizophrenia
Scientific and Clinical Report Sessions
Session 9. Buprenorphine Therapy
26. Challenges in Increasing Access to Buprenorphine Treatment Collaborative Session With the National Institute on Drug Abuse Joyce C. West, Ph.D.
27. A Double-Blind, Double-Dummy, Randomized, Prospective, Efficacy Study of the Partial Mu Opiate Agonist Buprenorphine for Acute Detoxification of Heroin Addicts Collaborative Session With the National Institute on Drug Abuse Michael R. Oreskovich, M.D.
28. Buprenorphine: An Effective Treatment for Heroin Addicts Paolo Marzorati, M.D.
Session 10. Panic Disorder
29. Early Detection of Relapse in Patients with Panic Disorder With Agoraphobia Supported by the National Institute of Health Matig R. Mavissakalian, M.D.
30. Three-Year Prophylaxis in Panic Disorder: To Continue or Discontinue? Yujuan Choy, M.D.
31. Discontinuation of Medications in Panic Patients Eric D. Peselow, M.D.
Session 11. Issues in Depression
32. Brain Bioenergetics and Thyroid Hormone Treatment in MDD Dan V. Iosifescu, M.D.
33. Depressed Outpatients From Primary Care Versus Specialty Care Settings Bradley N. Gaynes, M.D.
34. Limits to the Treatment of Major Depression Gabor I. Keitner, M.D.
Session 12. ADHD
35. ADHD Comorbidity in Preschool Children Atilla Turgay, M.D.
36. Atomoxetine for Comorbid ADHD and Affective Symptoms Jeffrey H. Newcorn, M.D.
37. Abuse Liability Assessment of Atomoxetine in a Drug-Abusing Population Donald R. Jasinsky, M.D.
Session 13. Understanding the Effects of Terrorism
38. Effects of 9/11 and Chronic Stress on Female Drinking and Anxiety Judith A. Richman, Ph.D.
39. Psychosocial Predictors of Long-Term Resilience Following the 9/11 Attacks David Spiegel, M.D.
40. The Terrorist as a Nonpatient Subject of Psychiatric Investigation David Rothstein, M.D.
Session 14. Psychopharmacology
41. Antipsychotic Treatment and Sexual Adverse Events: The Role of Prolactin Rikus Knegtering, M.D.
42. Three-Bead Extended-Release Carbamazepine Capsule (SPD417) Continuation: Maintenance Therapy in Bipolar Disorder Terence A. Ketter, M.D.
43. Parkinsonism in a Nursing Home: Underrecognition Hubert H. Fernandez, M.D.
Session 15. Issues in Psychiatric Research and Psychopharmacology
44. Concurrent Use of Multiple Antipsychotics in Psychiatric Inpatients Bonnie L. Szarek, R.N.
45. How Do Psychiatric Patients Perceive Research Participation? Cherise Rosen, M.A.
46. Polypharmacy and Its Ramifications in a Chronic Psychiatric Hospital Jambur V. Ananth, M.D.
Session 16. Child and Adolescent Psychiatry
47. Externalizing Behaviors in Preadolescent Children: A National Panel Study David J. Pevalin, Ph.D.
48. Gender and the Prediction of Drug and Alcohol Abuse in Adolescent Inpatients Daniel F. Becker, M.D.
49. Prevalence and Outcomes of Childhood Adversity in an Australian Population Stephen J. Rosenman, M.D.
Session 17. Social and Community Psychiatry
50. Evaluation of an HIV Intervention for Psychiatric Care Providers in South Africa Pamela Y. Collins, M.D.
51. Developing Capacity Within CBOS for Health Education and Outreach Mary Jane Massie, M.D.
52. Inter-European Countries Comparison on Treatment Use for Mental Health Disorders Viviane Kovess, M.D.
Session 18. Violence, Trauma, and Victimization
53. Evaluation of a Therapeutic Interagency Preschool for Traumatized Children Terrance J. Wade, Ph.D.
54. Mental Health in Postwar Afghanistan Barbara Lopes-Cardozo, M.D.
55. A Three-Dimensional Model of Violence in Schizophrenia Menahem I. Krakowski, M.D.
Component Workshops
CW27. Wherefore Neuroscience: How Much Does the Psychiatrist Need to Know? APA/GlaxoSmithKline Fellows Co-Chairpersons: Joshua L. Roffman, M.D. and Carrie L. Ernst, M.D.
CW28. What Do Employers Want? Employee Mental Health Benefits APA Committee on APA/Business Relationships Co-Chairpersons: Norman A. Clemens, M.D. and Jeffrey P. Kahn, M.D.
CW29. Helping District Branches Relate to APA and to Their Members APA Corresponding Committee on District Branch/State Association Relations Chairperson: Donald G. Langsley, M.D.
CW30. The Teaching of Gay, Lesbian, Bisexual, and Transgender Issues APA New York County District Branch’s Committee on Gay and Lesbian Issues Chairperson: Kenneth B. Ashley, M.D.
CW31. Sex, Drugs, and HIV: Synergistic Epidemics APANew York County District Branch’s AIDS Committee Co-Chairpersons: Kristina L.N. Jones, M.D. and John A.R. Grimaldi, Jr., M.D.
CW32. Looking Back, Looking Forward: Pathways for Blacks in Psychiatry APA Committee of Black Psychiatrists Co-Chairpersons: Michelle O. Clark, M.D. and N. Kalaya Okereke, M.D.
Issue Workshops
IW59. Approaching Moral Issues in Mental Health Treatment Chairperson: John R. Peteet, M.D.
IW60. The Portrayal of Psychiatry in Recent American Film Chairperson: Steven E. Pflanz, M.D.
IW61. How to Launch a Successful Private Practice (Part 2) Co-Chairpersons: William E. Callahan, Jr., M.D., Keith W. Young, M.D.
IW62. Using Art and Poetry: From Medication Management to Countertransference Chairperson: Charles R. Joy, M.D.
IW63. Psychiatric Rehabilitation and Psychodynamics Co-Chairpersons: Anand Pandya, M.D. and Grace Otto, R.N.
IW64. Management of Difficult Schizophrenia Chairperson: Michael Y. Hwang, M.D.
IW65. The Application of Bedside Executive-Function Measures Chairperson: Jeffrey A. Cordes, M.D.
IW66. The Psychiatry Resident as Educator: A Proposal for Curriculum and Supervision Co-Chairpersons: Ruth M. Lamdan, M.D. and Autumn Ning, M.D.
IW67. Interface Between Psychiatry and Obstetrics: Comprehensive Perinatal Care Chairperson: Johannes Bitzer
IW68. Closing a Psychiatric Practice: Clinical and Risk-Management Issues Chairperson: Robinette Bell, M.D.
IW69. Rehabilitating Traumatized Girls in Residential Juvenile- Justice Settings Chairperson: Cheryl D. Wills, M.D.
IW70. The Out-of-the-Shadow Project Co-Chairpersons: Edward F. Foulks, M.D. and Susan E. Smiley
IW71. Psychogenic Seizures: A Prototype of Somatoform Disorder Chairperson: Selim Benbadis, M.D.
IW72. Clinical Effects of Sexual Abuse by Catholic Priests: A Forensic Perspective Chairperson: Allan S. Nineberg, M.D.
IW73. Problems in the Psychiatric Education of International Medical Graduates Chairperson: Milton Kramer, M.D.
IW74. Drugs and Other Addictions: Does One Size Fit All? Collaborative Session With the National Institute on Drug Abuse Chairperson: Steven J. Grant, Ph.D.
IW75. Stress, Trauma, and Drug Abuse Collaborative Session With the National Institute on Drug Abuse Chairperson: Nancy Pilotte, Ph.D.
IW76. Children and Families Facing Terrorism, Disasters, and Complex Emergencies Chairperson: Howard J. Osofsky, M.D.
Noon-1:30 p.m.
Forums
6. Reversing the Criminalization of the Seriously Mentally Ill APA Corresponding Committee on Jails and Prisons Co-Chairpersons: Marcia Kraft Goin, M.D. and Henry C. Weinstein, M.D.
7. Unconscious Prediction, Conscious Monitoring, and Therapeutic Change: Is There a Mind-Brain Barrier? Chairperson: TBA
8. Should Sex Be Prevented in Psychiatric Units? Arguments and New Directions Chairperson: Milton L. Wainberg, M.D.
Noon-2 p.m.
New Research Poster Session 6
1 p.m.-5 p.m.
CME Courses 69-76
2 p.m.-3:30 p.m.
Lectures
L16. How Many Psychiatrists Do We Need? James H. Scully, Jr., M.D., Distinguished Psychiatrist Lecture Series
L17. Feeling and Healing: Biopsychosocial Treatments and Their Effects on Mental Illness David Spiegel, M.D., APA’s Marmor Award Lecture
L18. Conceptual and Methodological Flaws in the Evaluation of Addiction Treatment A. Thomas McLellan, Ph.D., Collaborative Session With the National Institute on Drug Abuse, Frontiers of Science Lecture Series
2 p.m.-5 p.m.
Presidential Symposium 2. Wither Go the States: The Impact of Budget Cuts Chairperson: David A. Pollack, M.D.
Symposia
S27. Behavioral Activation, Cognitive Therapy, and Medication for Major Depression
A. Methods and Acute-Phase Outcomes Sona A. Dimidjian
B. Prevention of Relapse Keith S. Dobson, Ph.D.
C. Prediction of Treatment Response Shireen Rizvi
S28. New Perspectives in the Treatment of Complex PTSD
A. Update on the Memory Wars: Evaluating and Working With Traumatic Memory James A. Chu, M.D.
B. Betrayal Trauma Theory: Dimensions of Harm and Healing Jennifer J. Freyd, Ph.D.
C. Significance of Relationship in the Treatment of Complex Trauma Christine Courtois, Ph.D.
D. Using EMDR to Resolve Trauma-Based Distortions of the Self in Complex PTSD Denise J. Gelinas, Ph.D.
E. Treatment Outcome Research and Complex PTSD Bessel A. Van Der Kolk, M.D.
S29. Bipolar Patients: Treatments and Cultural Issues in Latin America
A. Interpersonal Psychotherapy in Brazil: Similarities and Differences With the U.S. Ana C.F. Andrade, M.A.
B. From Practice to Theory: Group Music Therapy and Medication Compliance in Patients With Bipolar Disorder Ruby C. Castilla-Puentes, M.D.
C. What Is the Role of Psychotherapy in Patients With Bipolar Disorders? Cultural Issues Carlos Leon-Andrade, M.D.
D. Treatment of Sleep Problems in Bipolar Patients Franklin Escobar, M.D.
E. Some Useful Interventions in the Course of Bipolar Disorders in Argentina Jose R. Bozzo, M.D.
S30. Psychotherapy and Pharmacotherapy: Dissolving the Mind-Brain Barrier APA Committee on Psychotherapy by Psychiatrists
A. Dynamic Imaging of the Brain: Actions, Dysfunction, Therapeutic Transformation George I. Viamontes, M.D.
B. Psychotherapy and Pharmacotherapy: Theoretical Basis and Empirical Studies of Combined Treatment Michael E. Thase, M.D.
C. Split Treatment: Conflict and Collaboration Michelle B. Riba, M.D.
D. Integrating Psychotherapy and Pharmacotherapy: The Clinical Challenge Bernard D. Beitman, M.D.
S31. Practice Guidelines, Quality Indicators, and a Practice Research Network: An International View World Psychiatric Association
A. Treatment Guidelines in Psychiatry: Results of an International Survey Wolfgang Gaebel, M.D.
B. Clinically-Based Quality Indicators John M. Oldham, M.D.
C. APA Practice Guideline Project: Status and Challenges John S. McIntyre, M.D.
D. Assessing Evidence-Based Practice Guidelines in Routine Psychiatric Practice Darrel A. Regier, M.D.
S32. The Scars of SARS: Its Impacts on Patients, Health Care Workers, and the Community
A. PTSD and Depression in Patients Diagnosed With SARS Rima Styra, M.D.
B. The Psychological Impact of SARS on the Uninfected Health Care Worker Wayne L. Gold, M.D.
C. Stress in the Time of SARS: Health Care Workers’ Reactions to the Singapore SARS Outbreak Calvin Fones, M.D.
D. Impact of SARS on Health Care Professionals Sharon Straus, M.D.
E. I Am So Alone: Lessons Learned From Experiences of Quarantined Individuals During the SARS Outbreak in Toronto Laura Hawryluck, M.D.
S33. Interpersonal Psychotherapy: Research Update
A. Group Interpersonal Psychotherapy for Depression in Uganda Myrna M. Weissman, Ph.D.
B. Combination of IPT and Medication in Outpatients With Depression: Is It the Best We Can Do? Marc B.J. Blom, M.D.
C. IPT for Anxiety and Depression in Primary Care in Scotland Roslyn Law, Psy.D.
D. Brief Interpersonal Psychotherapy for Depression in Women Holly A. Swartz, M.D.
E. Long-Term Prophylaxis and Other Benefits of Maintenance Interpersonal Psychotherapy Ellen Frank, Ph.D.
S34. Women’s Sexuality Update: Overcoming Obstacles to Pleasure
A. How Sexual Attractiveness, Pheromones, Fertility, and Hysterectomy Are Related Winnifred B. Cutler, Ph.D.
B. Changes in Sexual Functioning Across the Menstrual Cycle and During and After Pregnancy Catherine A. Birndorf, M.D.
C. New Treatment Options for Women With Sexual Dysfunction Barbara D. Bartlik, M.D.
D. The Positive Uses of Adult Movies Catering to Women Candida Royalle
S35. Contemporary Issues in Sport Psychiatry International Society for Sport Psychiatry
A. FIST: A Unique Program for Boxers at Career End Ronald L. Kamm, M.D.
B. The Impact of Injury on the Adolescent Athlete and the Family Thomas S. Newmark, M.D.
C. Keeping the Athlete Out of Trouble Eric D. Morse, M.D.
S36. Eating Disorders 2004: From PETs to Psyche
A. Effects of Weight Loss on 5HT Activity and Symptoms in Anorexia Nervosa Walter H. Kaye, M.D.
B. Osteoporosis and Anorexia Nervosa: An Update David B. Herzog, M.D.
C. Predictors of Treatment Acceptance in Anorexia Nervosa Katherine A. Halmi, M.D.
D. Eating Problems and Disorders in Bariatric Surgery Patients James E. Mitchell, M.D.
E. Body Image: Evolutionary Neurobiology Meets Psychodynamic Psychiatry in the Agora Arnold E. Andersen, M.D.
S37. Psychiatric Interventions With Medically-Evacuated Soldiers
A. A Medical Center Response to Combat Casualties Thomas M. Fitzpatrick, M.D.
B. A Psychiatry Consultation Service Response to Trauma Victims: Program to Prevent Psychiatric Comorbidity Harold J. Wain, Ph.D.
C. Global War on Terror: Walter Reed Army Medical Center Inpatient Psychiatry’s Perspective Theodore S. Nam, M.D.
D. A Psychiatric Continuum of Care System in Support of the Global War on Terror Douglas A. Waldrep, M.D.
S38. How to Launch a Successful Private Practice (Part 3)
A. Personal Factors Leading to a Successful Private Practice William E. Callahan, Jr., M.D.
B. Office Location and Design for Efficiency and Success Keith W. Young, M.D.
C. Streamlining Overhead and Managing Your Business in Private Practice Keith W. Young, M.D.
D. Marketing Your Unique Private Practice William E. Callahan, Jr., M.D.
S39. Use of Mandates and Leverage in Community-Based Treatment
A. Leverage and Mandated Community Treatment John Monahan, Ph.D.
B. A Multisite Study of Mandated Community Treatment: Methods and Prevalence Henry J. Steadman, Ph.D.
C. When Are Mandates and Leverage Applied in Community Treatment? Paul S. Appelbaum, M.D.
D. Patients’ Attitudes Toward the Use of Legal Leverage in Community Treatment Jeffrey W. Swanson, Ph.D.
E. Mandated Treatment: Legal, Ethical, and Policy Implications Marvin S. Swartz, M.D.
S40. Perinatal Depression: Burden, Neurobiology, and Treatment
A. The Neuropsychobiology of Perinatal Mood Disorders: Are Hormonal Changes Relevant? Meir Steiner, M.D.
B. Perinatal Depression: Bridging the Gap Between Maternal Distress and Infant Well-Being Sheila Marcus, M.D.
C. The Undertreatment and Morbidity of Perinatal Depression in Obstetrics Settings Heather A. Flynn, Ph.D.
D. Mental Health Treatment Among Pregnant Underprivileged Women Kimberly A. Yonkers, M.D.
S41. Neuroimaging Seminar
A. Tools and Methods of Neuroimaging Research Perry F. Renshaw, M.D.
B. Functional Neuroanatomy of Psychiatric Disorders Deborah Yurgelun-Todd, Ph.D.
C. Neuroimaging in Psychotic Disorders Stephan H. Heckers, M.D.
D. Brain Imaging Studies of Depressive Illness Micheal E. Henry
E. Neuroimaging in Childhood Disorders Jean A. Frazier, M.D.
S42. Smoking and Comorbid Mental Disorders Collaborative Session With the National Institute on Drug Abuse
A. Psychiatric Comorbidity of Smoking and Nicotine Dependence: An Epidemiologic Perspective Naomi Breslau, Ph.D.
B. The Neurobiology of Nicotine Dependence and Comorbid Psychiatric Disorders George F. Koob, Ph.D.
C. Nicotine-Dependence Treatment in Individuals With Schizophrenia Douglas M. Ziedonis, M.D.
D. Behavioral and Pharmacological Treatments for Smokers With Depression Richard A. Brown, Ph.D.
S43. Tragic Events in the Emergency Department: The Role of Psychiatry and the Institutional Impact
A. Preparation and Organization for Tragedies in the Emergency Room Maryfran Hughes, R.N.
B. Managing Grief in the Group Setting Jennifer M. Lafayette, M.D.
C. Staff Support in Responding to Tragedies Lawrence T. Park, M.D.
D. Residency Training and Tragedy in the Emergency Department Felicia A. Smith, M.D.
S44. Culture, Ethnicity, Race, and Psychopharmacology: New Research Perspectives
A. Ethnicity, Pharmacogenetics, and Psychopharmacotherapy Keh-Ming Lin, M.D.
B. Pharmacotherapy in African Americans William B. Lawson, M.D.
C. Ethnicity, Culture, and Psychopharmacology: Asian Perspectives Edmond H.T. Pi, M.D.
D. Hispanics: Disease, Genes, and Treatment Outcome Ricardo P. Mendoza, M.D.
E. An International Perspective on Ethnicity, Culture, and Psychopharmacology Tarek A. Okasha, M.D.
S45. Delusional Disorder: A Reconsideration of the Scientific and Conceptual Basis for the DSM Reformulation of Paranoia
A. The Concept of Delusional Disorder in DSM-IV Nancy C. Andreasen, M.D.
B. The Importance of Narcissism in Delusional Disorders C. Robert Cloninger, M.D.
C. Delusional Disorder: The Validity of the Diagnosis Theo C. Manschreck, M.D.
D. Delusional Disorder: Does the DSM Diagnosis Make Clinical Sense? Alan A. Stone, M.D.
E. Involuntary Treatment: The Constitutional Issues Richard G. Taranto, J.D.
S46. Translational Research on Eating Disorders
A. Excitatory and Inhibitory Neurobiological Controls of Eating Gary J. Schwartz, Ph.D.
B. Dieting and Stress Combine Synergistically to Produce an Animal Model of Binge Eating Mary M. Hagan, Ph.D.
C. An Animal Model of Food Addiction That May Relate to Binge Eating or Bulimia Bartley G. Hoebel, Ph.D.
D. Symptom Profiles and 5HT Regulation in Bulimia Nervosa David C. Jimerson, M.D.
E. Inhibitory and Excitatory Controls of Eating in Patients With Eating Disorders Michael J. Devlin, M.D.
S47. What Every Psychiatrist Needs to Know About HIV/AIDS
A. Ten Things You Need to Know About Brain Dysfunction Steve Ferrando, M.D.
B. Five Things You Need to Know: Drug-Drug Interactions Marshall Forstein, M.D.
S48. Personality Disorders in the Workplace
A. Personality, Job Stress, and Mental Health Among Physicians Per Vaglum, M.D.
B. Avoidant and Dependent Personality Traits in the Workplace James H. Reich, M.D.
C. The Relationship Between Personality Disorders and Military Service Paul S. Links, M.D.
D. Interventions for Personality Disorders in the Workplace David P. Bernstein, Ph.D.
E. Personality Characteristics That Support Resuming of Interrupted Careers Elsa F. Ronningstam, Ph.D.
S49. Obsessive-Compulsive Spectrum Disorders: Update on Clinical Management
A. Neurobiology of the OCD Spectrum Dan J. Stein, M.D.
B. Obsessive-Compulsive Personality Disorder: Its Treatment and Relationship to OCD Jane L. Eisen, M.D.
C. Update on the Clinical Features and Treatment of BDD Katharine A. Phillips, M.D.
D. Identifying and Treating Hypochondriasis Jonathan Abramowitz, Ph.D.
E. Clinical Management of Pathological Gambling and Kleptomania Jon E. Grant, M.D.
S50. Genetic Correlates in Bipolar Disorders
A. Phenotype in Genetic Studies of Bipolar Disorder Martin Alda, M.D.
B. Pharmacogenetics of Bipolar Disorder Anil K. Malhotra, M.D.
C. Bipolar Disorder and Alcohol Abuse: Are There Shared Genetic Contributions? Joseph F. Goldberg, M.D.
D. Genetics of Suicidal Behavior in Bipolar Disorder Maria A. Oquendo, M.D.
E. Genetic Evidence for a Bipolar Spectrum J. Raymond DePaulo, Jr., M.D.
S51. Critical Perspectives on Gender Identity Disorder in Children and Adolescents
A. Diagnosing Gender-Atypical Youth: A History of Gender Identity Disorder in Childhood Karl E. Bryant, M.A.
B. Historical and Ethical Perspectives on Gender-Atypical and Transgender Youth Richard R. Pleak, M.D.
C. Transgender Teens: Gender Atypicality at Puberty and Beyond Sarah E. Herbert, M.D.
D. Gender Variance in Children and Adolescents: A Critical Reinterpretation of Case Studies Darryl B. Hill, Ph.D.
E. Childhood Gender Identity Disorder: What Should We Treat and Why? Edgardo J. Menvielle, M.D.
S52. The Art and Science of Brief Therapies
A. Solution-Focused Brief Therapy: Doing What Works Brett Steenbarger, Ph.D.
B. Brief Behavior Therapy Edna B. Foa, Ph.D.
C. Cognitive Therapy: Practice and Training Judith S. Beck, Ph.D.
D. The Impact of Common Factors on Psychotherapy Outcomes Roger P. Greenberg, Ph.D.
S53. The Boundaries of BPD
A. A New Examination of the Interface Between BPD and MDD John G. Gunderson, M.D.
B. Borderline or Bipolar? Donald W. Black, M.D.
C. Substance Abuse and Its Relationship to Remission From BPD Mary C. Zanarini, Ed.D.
D. Why Psychiatrists Do Not Diagnose BPD Joel F. Paris, M.D.
S54. Anticonvulsants for Treating Multiple Components of Alcohol-Dependence Syndrome
A. What Are the Critical Neurobiological Substrates Involved in the Development of Alcohol-Dependence? Raymond F. Anton, Jr., M.D.
B. What Is the Utility of Various Classes of Pharmacological Agents in Treating Different Components of the Alcohol-Dependence Syndrome? Robert M. Swift, M.D.
C. What Is the Effectiveness of Various Classes of Pharmacological Agents at Reducing Craving for Alcohol? Nassima Ait-Daoud, M.D.
D. How Effective Are Anticonvulsants at Treating Alcohol-Withdrawal Symptoms? Robert J. Malcolm, Jr., M.D.
E. How Effective Are Anticonvulsants at Improving the Overall Clinical Picture of Alcohol Dependence? Bankole A. Johnson, M.D.
S55. ADHD Subtypes and Subgroups at Risk for Substance Use Disorders Collaborative Session With the National Institute on Drug Abuse
A. Subtypes of ADHD Youth At Risk for Substance Abuse Timothy E. Wilens, M.D.
B. Childhood ADHD, Comorbidity, and Risk for Late-Adolescent Drug Abuse Ken C. Winters, Ph.D.
C. Developmental Twin Studies of Relations Between Substance Use and ADHD James J. Hudziak, M.D.
D. Variability in Risk for Substance Use and Disorder Among Children Diagnosed With ADHD Brooke S.G. Molina, Ph.D.
E. Behavioral and Cognitive Predictors of Adolescent Substance Use in Children With ADHD Jeffrey Halperin, Ph.D.
F. Long-Term Follow-Up of Childhood ADHD: Development of Adult Substance Abuse F. Xavier Castellanos, M.D.
S56. Alcoholics Anonymous and Spiritually Oriented Recovery
A. Research on Spirituality’s Role in Recovery Marc Galanter, M.D.
B. The Effectiveness of AA: Empirical Research Perspectives Barbara S. McCrady, Ph.D.
C. The Interaction Between AA and Personality Disorder Edgar Nace, M.D.
D. Integrating AA and Psychotherapy Richard K. Ries, M.D.
S57. An Update on Parkinson’s Disease and Its Psychiatric Complications
A. Parkinson’s Disease: Update on Treatment, Etiology, and Pathogenesis Margery Mark, M.D.
B. Depression in Parkinson’s Disease Jeffrey L. Cummings, M.D.
C. Psychosis in Parkinson’s Disease Laura Marsh, M.D.
D. Cognitive Impairment, Dementia, and Parkinson’s Disease Iracema Leroi, M.D.
E. Anxiety, Fatigue, and Sleep in Patients With Parkinson’s Disease Matthew A. Menza, M.D.
S58. Unipolar MDD: International Update APA Council on Global Psychiatry
A. MDD: A New Paradigm of Understanding and Treatment Lewis L. Judd, M.D.
B. A Psychobiological Model of Depression: Implications for Treatment Hagop S. Akiskal, M.D.
C. Predictive Factors in Resistant Depression: New European Data Julien Mendlewicz, M.D.
D. A New Public Health Agenda for Depression Norman Sartorius, M.D.
2 p.m.-5:30 p.m.
Review of Psychiatry (Section 2) Cognitive-Behavior Therapy Chairperson: Jesse H. Wright, M.D.
6. Cognitive Therapy for Schizophrenia Jan L. Scott, M.D.
7. Cognitive Therapy for Bipolar Disorder Monica A. Basco, Ph.D.
8. Computer-Assisted Cognitive-Behavior Therapy Jesse H. Wright, M.D.
9. Cognitive Therapy With Medical Patients Thomas Sensky, M.B.
10. Cognitive Therapy for Children and Adolescents Anne Marie Albano, Ph.D.
3 p.m.-5 p.m.
New Research Poster Session 7
7 p.m.-10 p.m.
Industry-Supported Symposia
IS43. Emotion Regulation and Plasicity of Underlying Circuitry: Implications for Depression, Anxiety, and Long-Term Brain Function Supported by Wyeth Pharmaceuticals
A. Amygdala and Prefrontal Cortical Interactions in Emotion Regulation and Psychopathology Ned H. Kalin, M.D.
B. Hippocampal Size in Depression: Cause and Effect Alan F. Schatzberg, M.D.
C. Dependent Effects on Neurogenesis in Limbic and Cortical Structures in Emotion Regulation Elizabeth Gould, Ph.D.
D. The Human Amygdala: Vigilance, Threat Assessment, and Psychopathology Paul Whalen, Ph.D.
IS44. Challenges in Treating Bipolar Illness and Comorbid Disorders Supported by Abbott Laboratories
A. Evidence-Based Utilization of Antiepileptic Drugs S. Nassir Ghaemi, M.D.
B. Integrated Treatment of Bipolar Disorder in Children and Adolescents Kiki D. Chang, M.D.
C. Bipolar Disorders in Women: Clinical and Metabolic Correlates Natalie L. Rasgon, M.D.
D. Recognizing and Treating Comorbid Depression and Anxiety in Bipolar Disorder Lori L. Davis, M.D.
E. The Challenge of Treating Bipolar Disorder and Substance Abuse Mark A. Frye, M.D.
IS45. Does the Pharmacology of Antidepressant Drugs Matter? Supported by GlaxoSmithKline
A. Antidepressant Treatment and the Effect of Medical and Psychiatric Comorbidity Dan V. Iosifescu, M.D.
B. Response Versus Remission: Are There Meaningful Differences Among Antidepressants? Michael E. Thase, M.D.
C. Short- and Long-Term Tolerability Issues With Antidepressants Anita L.H. Clayton, M.D.
D. Augmentation and Combination Strategies in Depression: What Is the Evidence? Maurizio Fava, M.D.
E. Translating Mechanisms of Action Into Clinical Outcome of Depression J. Craig Nelson, M.D.
IS46. Panic Anxiety: Understanding Its Nature and Nurturing Recovery Supported by Forest Laboratories, Inc.
A. Born or Made Anxious? The Role of Temperament and Environment Murray B. Stein, M.D.
B. Born or Made Anxious? Anxiety Disorder Gene Mapping and Identification Joel Gelernter, M.D.
C. Extreme Anxiety and Suicide David C. Purselle, M.D.
D. Treating Panic Disorder Using a Collaborative Care Approach in Primary Care Peter P. Roy-Byrne, M.D.
E. Choosing Medications for Panic Disorder Jonathan R.T. Davidson, M.D.
IS47. Adult ADHD Diagnosis and Treatment Supported by Shire US, Inc.
A. Adult ADHD: Clinical Overview Thomas J. Spencer, M.D.
B. Understanding and Utilization of Diagnostic Rating Scales Lenard A. Adler, M.D.
C. Cognitive-Behavioral Therapies: Treatments and Outcomes Stephen P. McDermott, M.D.
D. Treatment With Stimulants Timothy E. Wilens, M.D.
E. Treatment With Nonstimulants James G. Waxmonsky, M.D.
IS48. Binge Eating Disorder: Genes, Treatments, and Consequences Supported by Ortho-McNeil Pharmaceuticals
A. The Neurobiology of Binge Eating and Obesity James F. List, M.D.
B. Family and Genetic Studies of Binge Eating Disorder James I. Hudson, M.D.
C. Treatment of Binge Eating Disorder B. Timothy Walsh, M.D.
D. Psychiatric Comorbidity Associated With Binge Eating Disorder Justine K. Lalonde, M.D.
E. Addressing Medical Comorbidity Associated With Binge Eating Disorder Louis J. Aronne, M.D.
IS49. Exploring the True Morbidity of Insomnia Supported by Neurocrine Biosciences Inc.
A. Assessing the Complaint of Insomnia Mary B. O’Malley, M.D.
B. Metabolic and Endocrine Effects of Sleep Deprivation Eve Van Cauter, M.D.
C. Psychiatric Morbidity of Insomnia Ruth M. Benca, M.D.
D. Quality of Life and Associated Health Care Costs in Insomnia Daniel J. Buysse, M.D.
E. Current and Future Treatments of Insomnia John W. Winkelman, M.D.
Presidential Forum
I Am Sam Chairperson: Marcia Kraft Goin, M.D. ▪
